Publications en collaboration avec des chercheurs de University of Basel (23)

2024

  1. Mosquitocidal efficacy and pharmacokinetics of single-dose ivermectin versus three-day dose regimen for malaria vector control compared with albendazole and no treatment: An open-label randomized controlled trial

    International Journal of Infectious Diseases, Vol. 148

  2. Time since liver transplant and immunosuppression withdrawal outcomes: Systematic review and individual patient data meta-analysis

    Liver International, Vol. 44, Núm. 1, pp. 250-262

2023

  1. BOHEMIA: Broad One Health Endectocide-based Malaria Intervention in Africa—a phase III cluster-randomized, open-label, clinical trial to study the safety and efficacy of ivermectin mass drug administration to reduce malaria transmission in two African settings

    Trials, Vol. 24, Núm. 1

  2. Impact of body composition in advanced hepatocellular carcinoma: A subanalysis of the SORAMIC trial

    HEPATOLOGY COMMUNICATIONS, Vol. 7, Núm. 6

  3. Pharmacokinetics of ivermectin metabolites and their activity against Anopheles stephensi mosquitoes

    Malaria Journal, Vol. 22, Núm. 1

  4. The Lucerne Toolbox 2 to optimise axillary management for early breast cancer: a multidisciplinary expert consensus

    eClinicalMedicine, Vol. 61

  5. Uncertainties and controversies in axillary management of patients with breast cancer

    Cancer Treatment Reviews, Vol. 117

2022

  1. Corrigendum to “Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up”: [Annals of Oncology 29 suppl. 4 (2018) v238–iv255](S0923753419317119)(10.1093/annonc/mdy308)

    Annals of Oncology

  2. Oncoplastic breast consortium recommendations for mastectomy and whole breast reconstruction in the setting of post-mastectomy radiation therapy

    Breast, Vol. 63, pp. 123-139

2021

  1. A systematic review and an individual patient data meta-analysis of ivermectin use in children weighing less than fifteen kilograms: Is it time to reconsider the current contraindication?

    PLoS Neglected Tropical Diseases, Vol. 15, Núm. 3

  2. Potential metabolic resistance mechanisms to ivermectin in Anopheles gambiae: a synergist bioassay study

    Parasites and Vectors, Vol. 14, Núm. 1

  3. The pharmacokinetics and drug-drug interactions of ivermectin in Aedes aegypti mosquitoes

    PLoS Pathogens, Vol. 17, Núm. 3

2020

  1. Surgical Outcome and Oncological Survival of Osteofibrous Dysplasia-Like and Classic Adamantinomas: An International Multicenter Study of 318 Cases

    The Journal of bone and joint surgery. American volume, Vol. 102, Núm. 19, pp. 1703-1713

  2. Urticaria: Collegium Internationale Allergologicum (CIA) Update 2020

    International Archives of Allergy and Immunology, Vol. 181, Núm. 5, pp. 321-333

2019

  1. Dynamics and genomic landscape of CD8+ T cells undergoing hepatic priming

    Nature, Vol. 574, Núm. 7777, pp. 200-205

2018

  1. Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

    Annals of Oncology, Vol. 29, pp. iv238-iv255

  2. Oncoplastic Breast Consortium consensus conference on nipple-sparing mastectomy

    Breast Cancer Research and Treatment, Vol. 172, Núm. 3, pp. 523-537

  3. The prevalence of brucellosis and bovine tuberculosis in ruminants in Sidi Kacem Province, Morocco

    PLoS ONE, Vol. 13, Núm. 9

2017

  1. Cytochrome P450/ABC transporter inhibition simultaneously enhances ivermectin pharmacokinetics in the mammal host and pharmacodynamics in Anopheles gambiae

    Scientific Reports, Vol. 7, Núm. 1

  2. Cytomegalovirus infection management in solid organ transplant recipients across European centers in the time of molecular diagnostics: An ESGICH survey

    Transplant Infectious Disease, Vol. 19, Núm. 6